Skip to search.
 FTSE 100 Up 1.16%

More On AZN

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

AstraZeneca PLC (AZN)

-NYSE
33.02 Up 0.21(0.64%) 20:59
- NYSE Real Time Price
Add to Portfolio
Prev Close:32.81
Open:32.97
Bid:33.04 x 1200
Ask:33.06 x 300
1y Target Est:37.99
Beta:0.76
Next Earnings Date:N/A
Day's Range:32.77 - 33.09
52wk Range:31.61 - 38.12
Volume:1,696,389
Avg Vol (3m):2,715,750
Market Cap:41.74b
P/E (ttm):32.60
EPS (ttm):1.01
Div & Yield:1.90 (5.80%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNUp 0.64%41.74b
GSKUp 2.18%102.93b
MRKUp 1.77%165.39b
PFEUp 1.16%220.20b

Key Statistics

Forward P/E (1 yr):16.13
P/S (ttm):1.61
Ex-Dividend Date:18-Feb-15

Analysts

Annual EPS Est (Dec-15) :2.11
Quarterly EPS Est (Jun-15) :0.51
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):5.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback